Nootropics in New Zealand, cordyceps in South Korea, and the impact of China's daigou clampdown on companies like Swisse owner H&H all feature among our five most read stories on social media this month.
The intake of omega-3 fatty acids may have cardio-protective effects against air pollution, according to an RCT conducted by researchers in China and the US.
The consumption of elderberry (Sambucus nigra) has strong antiviral potential against influenza infection, especially in the later stages of the virus, researchers in Australia have found.
The use of multiple probiotic strains can help to accelerate the eradication of the bacterial species Helicobacter pylori and minimise side effects in the human body, according to a Chinese review.
DuPont is manufacturing a new probiotic strain for use in an upcoming large-scale clinical study in Bangladesh, which will test the effects of probiotics on gut microbiome of infants with sepsis.
From novel lactoferrin encapsulation technology in Singapore and plant-derived omega-3 in India to clinical research on cordyceps, glucosamine and ginger, get the latest scientific stories in our news round-up.
Dietary consumption of ginger could have long-term positive effects on type 2 diabetes mellitus (T2DM) patients, according to a systematic review conducted by Chinese researchers.
Scientists at India's Central Food Technological Research Institute (CFTRI) have discovered an oil crop that could potentially be on par with fish oil in terms of omega-3 content.
Asia-Pacific's growing ageing population has led to increased innovation in the bone and joint health supplement space, but products targeting more life stages and categories are also finding success in the sector.
Pharmako Biotechnologies is aiming to build a 'calendar of studies' that will fully explore the health benefits and variety of applications of its proprietary curcumin ingredient, HydroCurc.
The second phase of New Zealand's High-Value Nutrition National Science Challenge will see a significant portion of its work focused on China, alongside New Zealand and Singapore.
UK firm OptiBiotix is looking to increase its APAC presence, with Food Standards and Safety Authority of India (FSSAI) approval the latest development in its expansion plans withits weight management product, SlimBiome.
Read about Blackmores' strategy overhaul in the wake of weak Q3 results, Bod Australia's continuing CBD innovations, Sirio Pharma's global R&D plans, and probiotics news from BLIS Technologies and Indian start-up MO's Superfoods.
DuPont Nutrition & Health's XIVIA Xylitol will see its range of applications expand as scientific evidence continues to earn the ingredient approval in a growing number of countries.
CBD firm Bod Australia has embarked on a first-of-its-kind clinical trial on medical cannabis for Tourette syndrome patients, while continuing to expand its supplements business in countries with a more conducive regulatory environment than its home market.
